Stage III Oropharyngeal Squamous Cell Carcinoma

9 clinical trials · Condition

Record	Firm	Date
Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery (NCT03342911)	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	2017-11-13
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer (NCT02827838)	Wake Forest University Health Sciences	2017-01-01
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer (NCT02388932)	Case Comprehensive Cancer Center	2015-03-03
Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer (NCT02254278)	NRG Oncology	2014-10-01
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer (NCT01932697)	Mayo Clinic	2013-09-04
Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer (NCT01748942)	OHSU Knight Cancer Institute	2012-12-01
Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery (NCT02007200)	National Cancer Institute (NCI)	2009-07-01

Every clearance here is in the API, with alerts when new ones post.